Sandoz drives differentiated portfolio with deal to commercialize new treatment for Opioid- Induced Constipation in key European countries
Novartis continues transformation into a leading medicines company with completion of the Alcon spin- off
FDA approves Roche’s Tecentriq in combination with chemotherapy for the initial treatment of adults with extensive- stage small cell lung cancer
Internationally acknowledged expert becomes Endowed Professor for Preventive Dentistrymedicine and life sciences
By 2020, over 1.5 million people in the US are likely to have wet AMD, the leading cause of blindness in industrialized countries - Filing is based on Phase III data from the HAWK and HARRIER trials for brolucizumab - Novartis used a priority review voucher to expedite review of broluc
The University of Zurich coordinates a worldwide research project that focuses on the development of new biomarkers. The biomarkers are expected to improve safety of new drugs and to contribute to better diagnosis and management of acute and chronic diseases.
Researchers at the University of Zurich and from IBM Research have investigated the varying composition of cancer and immune cells in over one hundred breast tumors. They've found that aggressive tumors are often dominated by a single type of tumor cell.
Gait characteristics are sometimes regarded as the sixth vital sign in humans. They serve as a valuable indicator of a person's health, particularly in older adults - so why not measure them?
Selected Jobs
Professeur-e HES associé-e « Spécialisation en santé mentale et psychiatrie » HES-SO Genève
Postdoctoral Fellow Position in Machine Learning for Healthcare University of Bern
Doctoral position in Developing Visual Expertise for Differential Diagnosis (100%) Eidgenossische Technische Hochschule Zürich, ETHZ
Post-doctoral position in Cancer Cell Biology funded by Krebsliga University of Zurich
Last job offers
- Business/Economics - 19.4
Dozent/in Business Communication 80-100% - Media - 19.4
Digital Communication Manager/in 40-60% - Computer Science/Telecom - 17.4
Wissenschaftliche/r Mitarbeiter/in Data Science (60-100%) - Health - 17.4
Professeur-e HES associé-e « Spécialisation en santé mentale et psychiatrie »
Sandoz drives differentiated portfolio with deal to commercialize new treatment for Opioid- Induced Constipation in key European countries
Novartis continues transformation into a leading medicines company with completion of the Alcon spin- off
FDA approves Roche’s Tecentriq in combination with chemotherapy for the initial treatment of adults with extensive- stage small cell lung cancer